HomeCompareCBSC vs EQR

CBSC vs EQR: Dividend Comparison 2026

CBSC yields 6666.67% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBSC wins by $1028095347812062.00M in total portfolio value
10 years
CBSC
CBSC
● Live price
6666.67%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1028095347812062.00M
Annual income
$998,628,545,336,266,700,000.00
Full CBSC calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — CBSC vs EQR

📍 CBSC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBSCEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBSC + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBSC pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBSC
Annual income on $10K today (after 15% tax)
$566,666.67/yr
After 10yr DRIP, annual income (after tax)
$848,834,263,535,826,600,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, CBSC beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBSC + EQR for your $10,000?

CBSC: 50%EQR: 50%
100% EQR50/50100% CBSC
Portfolio after 10yr
$514047673906031.00M
Annual income
$499,314,272,668,133,360,000.00/yr
Blended yield
97.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CBSC
No analyst data
Altman Z
-87.0
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBSC buys
0
EQR buys
0
No recent congressional trades found for CBSC or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBSCEQR
Forward yield6666.67%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1028095347812062.00M$40.5K
Annual income after 10y$998,628,545,336,266,700,000.00$3,819.61
Total dividends collected$1026118102492338.88M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CBSC vs EQR ($10,000, DRIP)

YearCBSC PortfolioCBSC Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$677,367$666,666.67$11,248$547.57+$666.1KCBSC
2$42,928,313$42,203,530.63$12,701$666.53+$42.92MCBSC
3$2,545,616,701$2,499,683,405.64$14,405$814.59+$2545.60MCBSC
4$141,255,910,403$138,532,100,533.89$16,413$999.84+$141255.89MCBSC
5$7,335,374,338,812$7,184,230,514,680.15$18,795$1,232.92+$7335374.32MCBSC
6$356,516,885,536,661$348,668,034,994,132.70$21,639$1,527.95+$356516885.52MCBSC
7$16,218,956,689,966,618$15,837,483,622,442,392.00$25,057$1,903.80+$16218956689.94MCBSC
8$690,711,023,145,868,900$673,356,739,487,604,600.00$29,197$2,385.87+$690711023145.84MCBSC
9$27,539,067,734,387,980,000$26,800,006,939,621,900,000.00$34,250$3,008.70+$27539067734387.95MCBSC
10$1,028,095,347,812,062,000,000$998,628,545,336,266,700,000.00$40,467$3,819.61+$1028095347812062.00MCBSC

CBSC vs EQR: Complete Analysis 2026

CBSCStock

Cardiac Biotech Solutions Inc., through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians. Cardiac Biotech Solutions' wholly owned U.S. subsidiary, My-Cardia (USA), Inc., develops ECG recording device worn by patients in an ambulatory setting for up to 30 days.

Full CBSC Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CBSC vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBSC vs SCHDCBSC vs JEPICBSC vs OCBSC vs KOCBSC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.